D-Optimal mixture design: Optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms

Drug Development and Industrial Pharmacy

Volumn 32, Issue 10, 2006, Pages 1207-1218

  El Malah, Yasser ^a   Nazzal, Sami ^a   Khanfar, Nile M ^b  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Controlled release; D optimal design; Dissolution; Hydrophilic matrices; Optimization; Response surface methodology

Indexed keywords

BUFFER; CARBOMER; LACTOSE; MACROGOL; PHOSPHATE; POLYOX; THEOPHYLLINE;

ARTICLE; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG DESIGN; DRUG DOSAGE FORM; DRUG SOLUBILITY; IN VITRO STUDY; PH; RESPONSE SURFACE METHOD; TABLET; TABLET FORMULATION;

ACRYLATES; ADMINISTRATION, ORAL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DESIGN; HUMANS; LACTOSE; POLYETHYLENE GLYCOLS; TABLETS; THEOPHYLLINE;

EID: 33750884087     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600685167     Document Type: Article

References (28)

1. Bloomfield, M. S., & Butler, W. C. (2000). Robustness testing, using experimental design of a flow-through dissolution method for a product where the actives have markedly differing solubility properties. Int. J. Pharm., 206, 55-61.
2. Bolton, S. (1990). Pharmaceutical Statistics: Practical and Clinical Application (Revised and Expanded, 2nd Ed.); New York: Marcel Dekker, Inc.
3. Busse, W. W., & Lemanske, R. F. (2001). Asthma. N. Engl. J. Med., 344, 350-362.
4. Center for Drug Evaluation and Research (CDER). (1997). Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Rockville, MD: Food and Drug Administration.
5. Fan, L. T., Singh, S. K. (1989). Controlled Release. Berlin: Springer-Verlag.
6. Gao, P., Witt, M. J., Haskell, R. J., Zamora, K. M., & Shifflett, J. R. (2004). Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm. Dev. Technol., 9, 1-9.
7. Hansel, T. T., Tennant, R. C., Tan, A. J., Higgins, L. A., Neighbour, H., Erin, E. M., & Barnes, P. J. (2004). Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease. Drugs of Today, 40, 55-69.
8. Jantzen, G. M., & Robinson, J. R. (2002). Sustained and Controlled-Release Drug-Delivery System. In G. S. Banker, & C. T. Rhodes, (Eds.), Modern Pharmaceutics (pp. 501-528). New York: Marcel Dekker, Inc.
9. Ju, R. T. C., Nixon, P. R., & Patel, M. V. (1997). Diffusion coefficient of polymer chains in the diffusion layer adjacent to a swollen hydrophilic matrix. J. Pharm. Sci., 86, 1293-1298.
10. Ju, R. T. C., Nixon, P. R., Patel, M. V., & Tong, D. M. (1995). Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J. Pharm. Sci., 84, 1464-1477.
11. Jumaa, M., Kleinebudde, P., & Muller, B. W. (1999). Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers. Pharm. Acta Helv., 73, 293-301.
12. Kim, C. J. (1994). Drug Release from Compressed Hydrophilic POLYOX-WSR Tablets. J. Pharm. Sci., 84, 303-306.
13. Kim, H., & Fassihi, A. R. (1997). Application of a binary polymer system in drug release rate modulation: 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci., 86, 323-328.
14. Kincl, M., Vrecer, F., & Veber, M. (2004). Characterization of factors affecting the release of low solubility drug from prolonged release tablets. Anal. Chim. Acta, 502, 107-113.
15. Korsmeyer, R. W., Gurney, R., Doelker, E., Buri, P., & Peppas, N.A. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm., 15, 25-35.
16. Lee, L. (1992). Diffusion-controlled matrix system. In A. Kydonieus (Ed.), Treatise on Controlled Drug Delivery (pp. 155-198). New York: Marcel Dekker, Inc.
17. Lyman, D. J., & Kim S. W. (1973). Aqueous diffusion through partition membranes. J. Polym. Sci.: Polym. Symp., 41, 139-144.
18. Mannino, D. M., Homa, D. M., & Pertwski, C. A. (1998). Surveillance for asthma-United States, 1960-1995. MMWR CDC Surveil. Summ., 47, 1-27.
19. Moore, J. W., & Flanner, H. H. (1996). Mathematical comparison of dissolution profiles. Pharm. Tech., 20, 64-74.
20. Nazzal, S., Nutan, M., Palamakula, A., Shah, R., Zaghloul, A. A., & Khan, M. A. (2002). Optimization of a self-emulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int. J. Pharm., 240, 103-114.
21. Parojcic, J., Duric, Z., Jovanovic, M., Ibric, S., & Nicolic, L. (2001). Influence of pH and agitation intensity on drug dissolution from tablets evaluated by means of factorial design. Pharm. Ind., 63, 774-779.
22. Peppas, N. A. (1998). Hydrogels in Medicine and Pharmacy, Vols. I, II and III. Boca Raton, FL: CRC Press.
23. Peppas, N. A., & Sinclair, J. L. (1983). Anomalous transport of penetrants in glassy polymers. Colloid Polymer Sci., 261, 404-408.
24. Reilly, W. J. (2005). Pharmaceutical necessities. In A. R. Genarro (Ed.), Remington's Pharmaceutical Science (21st Ed.) (pp. 1058-1092). Mack Publishing: Easton, PA.
25. Sastry, A. V., & Khan, M. A. (1998). Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system. Pharm. Dev. Technol., 3, 423-432.
26. 2. Pharm. Res., 15, 889-896.
27. Siepmann, J., Streubel, A., & Peppas, N.A. (2002). Understanding and prediction drug delivery from hydrophilic matrix tablets using the sequential layer model. Pharm. Res., 19, 306-313.
28. Yang, L., & Fassihi, R. (1996). Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. J. Pharm. Sci., 85, 170-173.